LISA HASAN: Open Payments
NPI 1902832801 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,383 in 122 payments from 14 companies in 2025. Trend: 2023 $1,031 · 2024 $1,466 · 2025 $2,383
Food & beverage: $2,383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $484 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $425 |
| Neurocrine BioSciences, Inc. | 23 | $424 |
| Supernus Pharmaceuticals, Inc. | 24 | $217 |
| Corium, LLC | 9 | $168 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| Axsome Therapeutics, Inc. | 5 | $123 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $77 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Qelbree, Azstarys, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
